All Stories

  1. Reduced adherence to antiretroviral therapy is associated with residual low-level viremia

    Article • Pragmatic and Observational Research, May 2017, Dove Medical Press

    GIACOMO MATTEO BRUNO, SERGIO DI MATTEO, franco maggiolo, Marco Rizzi

  2. Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers

    Article • Therapeutics and Clinical Risk Management, October 2015, Dove Medical Press

    GIACOMO MATTEO BRUNO, Roberto Ganga

  3. Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation

    Article • Patient Related Outcome Measures, February 2015, Taylor & Francis

    franco maggiolo, GIACOMO MATTEO BRUNO, SERGIO DI MATTEO

  4. Economic and outcomes consequences of TachoSil®: a systematic review

    Article • Vascular Health and Risk Management, September 2014, Dove Medical Press

    Gaetano Mauro, GIACOMO MATTEO BRUNO, SERGIO DI MATTEO

  5. Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women

    Article • Therapeutics and Clinical Risk Management, June 2014, Taylor & Francis

    GIACOMO MATTEO BRUNO

  6. Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines

    Article • ClinicoEconomics and Outcomes Research, October 2013, Taylor & Francis

    GIACOMO MATTEO BRUNO, SERGIO DI MATTEO

  7. A cost-of-illness study of spina bifida in Italy

    Article • ClinicoEconomics and Outcomes Research, July 2013, Taylor & Francis

    Dr Maria Paola Pascali, GIACOMO MATTEO BRUNO, SERGIO DI MATTEO

  8. Cost and appropriateness of treating asthma with fixed-combination drugs in local health care units in Italy

    Article • ClinicoEconomics and Outcomes Research, December 2012, Taylor & Francis

    GIACOMO MATTEO BRUNO, SERGIO DI MATTEO

  9. Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation

    Article • ClinicoEconomics and Outcomes Research, September 2012, Taylor & Francis

    GIACOMO MATTEO BRUNO, SERGIO DI MATTEO

  10. Antidiabetic therapy in real practice: indicators for adherence and treatment cost

    Article • Patient Preference and Adherence, September 2012, Taylor & Francis

    GIACOMO MATTEO BRUNO

  11. Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy

    Article • Therapeutics and Clinical Risk Management, September 2012, Taylor & Francis

    GIACOMO MATTEO BRUNO, SERGIO DI MATTEO

  12. Acamprosate in the treatment of alcoholism: a budget impact analysis for the National Health Service in Italy

    Article • Substance Abuse and Rehabilitation, July 2012, Taylor & Francis

    GIACOMO MATTEO BRUNO, SERGIO DI MATTEO

  13. Burden of Crohn’s disease: economics and quality of life aspects in Italy

    Article • ClinicoEconomics and Outcomes Research, July 2012, Taylor & Francis

    GIACOMO MATTEO BRUNO, VIVIANO BENEDINI

  14. Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer

    Article • Cancer Management and Research, March 2012, Taylor & Francis

    GIACOMO MATTEO BRUNO, GIORGIO LORENZO COLOMBO

  15. Cost-effectiveness analysis of initial HIV treatment under Italian guidelines

    Article • ClinicoEconomics and Outcomes Research, October 2011, Taylor & Francis

    GIACOMO MATTEO BRUNO

  16. Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A

    Article • ClinicoEconomics and Outcomes Research, March 2011, Taylor & Francis

    GIACOMO MATTEO BRUNO

  17. A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy

    Article • ClinicoEconomics and Outcomes Research, February 2011, Taylor & Francis

    GIACOMO MATTEO BRUNO

  18. A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy

    Article • ClinicoEconomics and Outcomes Research, October 2009, Taylor & Francis

    GIACOMO MATTEO BRUNO

  19. Erratum: An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia. Neuropsychiatr Dis Treat, 4: 967–976

    Article • Neuropsychiatric Disease and Treatment, February 2009, Dove Medical Press

    GIACOMO MATTEO BRUNO

  20. An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia

    Article • Neuropsychiatric Disease and Treatment, August 2008, Dove Medical Press

    GIACOMO MATTEO BRUNO